Shares of Allos Therapeutics (ALTH) move up 8.1% premarket on chatter that the firm could be a...

|About: Allos Therapeutics, Inc. (ALTH)|By:, SA News Editor

Shares of Allos Therapeutics (ALTH) move up 8.1% premarket on chatter that the firm could be a beneficiary of the decision by Cell Therapeutics (CTIC) to withdraw its NDA with the FDA.